Skip to content

PTH

GradeCNASDAQ Global Market

Invesco Dorsey Wright Healthcare Momentum ETF

Sectors · Invesco · Inception 2006-10-12 · SEC filings

$60.60−1.82 (−2.91%)

As of Sep 23, 2026, 3:05 PM EDT

Intraday session: down, 67 prints from 62.42 to 60.60. Range 60.37 to 62.23. Use the arrow keys to read each point.$61.00$61.50$62.0010 AM12 PM2 PM4 PM
Expense ratio
0.74%
Fund size
$292M
1Y return
+56.9%
Yield · Last 12 months
2.45%
Holdings
55
Volume · 30D
0M sh
NAV per share
$61.51
52W range
low $41.05high $64.10

The ETF.net PTH Grade

C

47/ 100

Rank 15 of 25 in Health Care (Broad)

Confidence Medium

Six-pillar profile for PTH. Scores out of 100: Cost 25, Risk 49, Mission not scored, Tradability 68, Holdings 71, Durability 71. Strongest: Holdings (71). Weakest: Cost (25). Based on 5 of 6 pillars.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 47 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    DScore 25
    Category rank19/25 · bottom quartile
  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    Not scored
  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    CScore 49
    Category rank14/24 · mid-pack
  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    BScore 68
    Category rank7/25 · top 28%
  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    AScore 71
    Category rank9/25 · top 36%
  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    AScore 71
    Category rank8/25 · top 32%

Graded as of Sep 22, 2026 · Based on 5 of 6 pillars

Our read on PTH

ETF.net Research

CHealthcare, ranked by price strength. PTH holds the health care names Dorsey Wright's relative-strength screen rates strongest, then reshuffles the list every quarter. Momentum logic applied to one sector instead of the whole market, running since 2006.

Stated mandate

The Fund seeks to track the performance of its underlying index before fees and expenses. The index selects healthcare companies exhibiting relative strength or momentum.

Why people hold it

  1. 01The screen does the work: the index pulls at least 30 health care names out of the NASDAQ US Benchmark Index based on relative strength, and re-ranks them quarterly. No manager hunches.invesco.com
  2. 02Trading since 2006, so this is a long-running strategy that has been through multiple healthcare cycles rather than a recently launched idea.
  3. 03Concentrated by design: about 60 names means the leaders the screen picks actually move the fund, unlike broad sector funds where hundreds of tickers water each other down.
  4. 04No drift at the fund level. It normally keeps at least 90% of total assets in index constituents, so what the momentum screen selects is what you own.invesco.com

Worth knowing

  1. 01Cost is the headline trade-off: 0.72% a year, more than double the 0.32% median for its factor peer group and far above broad index peers like VYM and IUSG at 0.04%.
  2. 02A thinly traded fund, so bid-ask spreads can run wider than in the big sector ETFs and order size matters more than it would in a household-name product.
  3. 03Momentum drops what fades and adds what leads, every quarter. That turnover is the strategy working as written, but the roster can look very different one year to the next.invesco.com

PTH Holdings

As of Sep 20, 2026, 1:49 PM
Asset class
Stocks
Holdings
55
Top-10 weight
39%
Largest holding
ROIV5.5%

Sectors

  • Health Care99.9%
  • Financials0.1%

Geography

  • United States89.73%
  • United Kingdom6.16%
  • Ireland2.67%
  • Netherlands1.44%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001ROIVRoivant Sciences Ltd5.50%401,107$16M168
002GHGuardant Health Inc5.23%84,529$15M171
003MRNAModerna Inc5.05%95,072$15M240
004RVMDRevolution Medicines Inc4.76%72,379$14M169
005AXSMAxsome Therapeutics Inc3.72%51,974$11M106
006BTSGBrightSpring Health Services Inc3.63%185,477$11M153
007TXG10X Genomics Inc3.49%132,058$10M136
008TWSTTwist Bioscience Corp2.75%47,722$8M123
009ORKAOruka Therapeutics Inc2.55%77,885$7M89
010ILMNIllumina Inc2.30%27,867$7M305
011TVTXTravere Therapeutics Inc2.30%106,198$7M109
012LQDALiquidia Corp2.27%98,456$7M112
013ERASErasca Inc2.27%445,288$7M82
014RLAYRelay Therapeutics Inc2.13%328,575$6M93
015REPLReplimune Group Inc2.13%473,498$6M56

Showing 1–15 of 56 holdings

PTH Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

PTH$15,690
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. PTH $15,690. SPY $11,723. Use the arrow keys to read each point.$9,005$12,818$16,631Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PTH. Periods over one year show the average yearly return.
PeriodPTH
Year to date+25.6%
1 month−0.9%
3 months+14.5%
1 year+56.9%
3 years+24.3%per year
5 years+2.4%per year
10 years+13.5%per year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PTH
YearReturn barPTH
2026 YTD+25.6%
2025+27.9%
2024+2.4%
2023−4.5%
2022−20.6%
2021−3.2%
2020+67.3%

PTH in the news

ETF.net Research hasn’t filed on PTH yet — coverage lands here as it’s written.

PTH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
2.45%Last 12 months
Payout per share
$1.53Last 12 months
Last payment
$1.53 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution history

2017–2026

One bar per payment. 2 payments from 2017 to 2026 YTD. Jun 24, 2024 $0.03; Dec 22, 2025 $1.53. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Dec 22, 2025Dec 26, 2025$1.53
Jun 24, 2024Jun 28, 2024$0.03
Dec 20, 2013Dec 31, 2013$0.01
Sep 20, 2013Sep 30, 2013$0.0027
Jun 21, 2013Jun 28, 2013$0.04
Dec 21, 2012Dec 31, 2012$0.11
Jun 15, 2012Jun 29, 2012$0.0084
Dec 18, 2009Dec 31, 2009$0.02
Jun 19, 2009Jun 30, 2009$0.0083

PTH Risk

How much the fund’s monthly returns vary, scaled to a year.
25.6%
Annualised · 36 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.64
vs 3-month T-bills · to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−49.8%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.97
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

PTH Cost

Expense ratio0.74%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

18 of the 25 Health Care (Broad) funds charge less.

PTH costs $74.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.